Ligandrol (LGD-4033)-Induced Liver Injury.
Journal
ACG case reports journal
ISSN: 2326-3253
Titre abrégé: ACG Case Rep J
Pays: United States
ID NLM: 101638398
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
22
10
2019
accepted:
18
02
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
We described a 32-year-old man who developed severe drug-induced liver injury after using Ligandrol (LGD-4033). The diagnosis was confirmed by a liver biopsy that showed cholestatic hepatitis with a mild portal, periportal, and perisinusoidal fibrosis. Ligandrol is a selective androgen receptor modulator that is available over the counter and via the internet.
Identifiants
pubmed: 32637435
doi: 10.14309/crj.0000000000000370
pii: ACGCR-19-0750
pmc: PMC7304490
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e00370Informations de copyright
© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
Références
J Bone Miner Metab. 2019 Mar;37(2):243-255
pubmed: 29785666
J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):87-95
pubmed: 22459616
Hepatology. 2008 Jun;47(6):2003-9
pubmed: 18454504
JAMA. 2017 Nov 28;318(20):2004-2010
pubmed: 29183075
Oncol Lett. 2017 Dec;14(6):8066-8071
pubmed: 29344250
J Med Chem. 2016 Jan 28;59(2):750-5
pubmed: 26683992
Sex Med Rev. 2019 Jan;7(1):84-94
pubmed: 30503797
Mol Cell Endocrinol. 2018 Mar 15;464:34-45
pubmed: 28137616
Adv Exp Med Biol. 2019;1141:293-340
pubmed: 31571168
Curr Opin Support Palliat Care. 2013 Dec;7(4):345-51
pubmed: 24189892
Chem Rev. 2005 Sep;105(9):3352-70
pubmed: 16159155